The UK government announced this Tuesday (14) that an additional dose of the vaccine against COVID-19 For people over 50 years of age, health workers, asylum workers, as a means to strengthen immunity against disease.
The decision was made after the British CEO, led by Prime Minister Boris Johnson, received the green light from an advisory group formed by experts in the field, which recommended the use of the vaccine jointly produced by Pfizer Laboratories and BionNTech.
In addition, the team assisting the government with the prevention and control of the novel coronavirus has indicated that it is safe to give a booster dose against the coronavirus at the same time as the influenza vaccine, which is given annually in the UK in the winter. .
The government has also informed that people within the at-risk group, as well as anyone else between the ages of 16 and 65 who is at risk in the event of contracting the novel coronavirus, will also be entitled to a booster dose.
The Oxford/AstraZeneca, Pfizer, and Moderna vaccines were deemed safe for the third dose, however, experts recommended the second dose, seeing it as better tolerated and more responsive when used as a booster.
An immunizing agent developed by American pharmaceuticals can be used for those who previously received two doses of the Oxford vaccine.
According to the government plan, a person who received the second injection six months ago will be able to receive the vaccine for the third time.
The specialists, when they have sufficient data on their hands, will evaluate the expansion of the dose application to the rest of the population.
England’s deputy medical director, Jonathan Van Tam, issued a warning, at a press conference, saying the country had to go through a “harsh” winter, and telling residents that the COVID-19 pandemic was still “active”.
Also, on Tuesday, the British Prime Minister, Boris Johnson, is expected to deliver a statement detailing the measures for the coming months aimed at curbing the spread of the novel coronavirus, at a press conference as well.
